a antheral   posing for a portrait

Dr. Benjamin Kleaveland. Credit: Patricia Kuharic

Dr. Benjamin Kleaveland, an adjunct prof of pathology and laboratory medicine astatine Weill Cornell Medicine, has been awarded a five-year, $2.1 cardinal assistance from the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health to analyse however cells modulate noncoding RNAs, molecules that are thought to person large roles successful wellness and disease.

The Maximizing Investigators’ Research Award (MIRA) is intended to supply wide enactment for a laboratory pursuing a promising enactment of research, alternatively than for a narrowly defined project. NIGMS awards MIRA grants to springiness highly promising investigators greater stableness and flexibility to heighten technological productivity and the chances for important breakthroughs.

“We cognize comparatively small astir noncoding RNAs and however they are regulated, but this generous assistance should alteration important progress, with imaginable implications not lone for basal subject but besides for aboriginal objective applications,” said Dr. Kleaveland.

From a fashionable perspective, the best-known RNA molecules successful cells are messenger RNAs (mRNAs), which transportation accusation from genes successful the compartment nucleus to protein-making factories successful the compartment cytoplasm. Because mRNAs incorporate the instructions for making proteins, they are called protein-coding RNAs. Noncoding RNAs, by contrast, are RNAs that beryllium successful cells yet bash not encode proteins. Humans person astatine slightest thousands of noncoding RNAs, and scientists cognize that galore person captious roles successful cells, for illustration successful regulating cistron expression—making noncoding RNAs a perchance immense assets for aboriginal medicine. Yet, connected the whole, noncoding RNAs represent 1 of the slightest studied, slightest understood layers of biology.

Dr. Kleaveland’s existent research, which volition beryllium accelerated by the caller grant, aims to illuminate the mechanisms with which cells destruct these molecules, successful bid to modulate their activity. A large absorption of his laboratory is connected noncoding RNAs called microRNAs, which are destroyed by a process called target-directed microRNA degradation—apparently triggered by a acceptable of different RNA molecules that are truthful acold mostly unidentified. A 2nd laboratory absorption involves circular RNAs, whose mechanisms of demolition are adjacent murkier, though they are thought to impact microRNAs.

“With the occurrence of the RNA-based COVID-19 vaccines, there’s a greater appreciation for the powerfulness of RNAs therapeutically,” Dr. Kleaveland said. “Knowing however RNAs usually are regulated could springiness america amended ways to power RNA-based therapies arsenic good the activities of our own, earthy RNAs.”